Pediatric Lithium Initiation Dosing
For children ≥12 years and ≥30 kg, initiate lithium carbonate at 900 mg/day (300 mg three times daily), with dose increases of 300 mg weekly based on clinical response and serum levels, targeting therapeutic levels of 1.0-1.2 mEq/L for acute mania. 1
Starting Dose Strategy
The evidence strongly supports weight-based dosing:
- Children weighing ≥30 kg: Start at 300 mg three times daily (900 mg/day total) 1
- Children weighing <30 kg: Start at 300 mg twice daily (600 mg/day total) 1
- Alternative calculation: 30 mg/kg/day divided into two or three doses 2, 3
The research demonstrates that starting at 900 mg/day in children ≥30 kg, with an additional 300 mg increase during the first week, followed by weekly 300 mg increases, achieved a 58% response rate with good tolerability 1. This aggressive initial approach proved as effective and safe as more conservative strategies.
Titration Guidelines
Weekly dose adjustments are the standard:
- Increase by 300 mg/day increments at weekly intervals 1
- Base increases on both clinical response and serum lithium levels
- For acute mania, target serum levels of 1.0-1.2 mEq/L 4, 3
- Typical maintenance doses range from 900-1800 mg/day in divided doses 4
The FDA label specifies that optimal response in acute mania typically requires 600 mg three times daily (1800 mg/day), producing effective serum levels of 1.0-1.5 mEq/L 4. However, pediatric patients often achieve response at lower total daily doses when weight-adjusted dosing is used 5.
Target Serum Levels by Phase
Acute treatment phase:
Maintenance phase:
Critical Monitoring Requirements
Before initiating lithium 6:
- Complete blood count
- Thyroid function tests (TSH, free T4)
- Urinalysis
- BUN and creatinine
- Serum calcium
- Pregnancy test in adolescent females
During titration:
- Serum lithium levels twice weekly until stable 4
- Draw levels 8-12 hours post-dose (trough levels) 4
- Clinical assessment weekly
After stabilization 6:
- Lithium levels every 3-6 months
- Renal function (BUN, creatinine) every 3-6 months
- Thyroid function every 3-6 months
- Urinalysis every 3-6 months
Important Caveats
Age restriction: The FDA label explicitly states lithium is not recommended for children under 12 years due to insufficient safety and efficacy data 4. Despite this, the research evidence includes younger children (as young as 6-7 years) 2, 1, suggesting off-label use occurs with appropriate monitoring.
Drug interactions requiring dose reduction 4:
- Diuretics (thiazides, loop diuretics)
- ACE inhibitors
- NSAIDs (particularly indomethacin, piroxicam, celecoxib)
- These medications reduce lithium clearance and necessitate more frequent monitoring
Toxicity warning signs 4:
- Diarrhea, vomiting
- Tremor, mild ataxia
- Drowsiness, muscular weakness
- Patients/families must be instructed to discontinue lithium and contact physician immediately if these occur
Practical Dosing Algorithm
- Verify weight: If ≥30 kg, start 300 mg TID; if <30 kg, start 300 mg BID
- Week 1: Consider increasing by additional 300 mg if well-tolerated
- Weeks 2-6: Increase by 300 mg weekly based on:
- Clinical response (target ≥50% reduction in mania symptoms)
- Serum levels (target 1.0-1.2 mEq/L for acute phase)
- Tolerability
- Stop titration when: Response achieved, target level reached, or intolerable side effects emerge
- Transition to maintenance: Reduce target to 0.6-1.2 mEq/L after acute stabilization
The population pharmacokinetic modeling supports a maintenance dose of approximately 25 mg/kg/day in two divided doses for sustained response, though this requires individualized adjustment based on therapeutic drug monitoring 5.